Biotech ETFs are riding innovation, obesity drug growth and M&A, offering diversified exposure to the sector???s powerful ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing Friday, the latest large healthcare company to ...

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

TScan has told Fierce that its pipeline strategy remains unchanged despite Amgen walking away from a Crohn’s disease ...

Three days ago, on August 4, Amgen ( AMGN) released another strong earnings report. Its revenue was $10.1 billion, up 16.6% ...

June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that supported approval of Amgen’s (AMGN.O), opens new tab rare-disease drug, citing ...

Drugmaker Amgen said on Friday hackers stole company data and patient health information in a ​cybersecurity incident involving cloud storage systems run by third-party ‌providers, becoming the latest ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud ...